(22R)-Budesonide
CAS: 51372-29-3
Ref. 3D-FB19347
| 1mg | Discontinued | ||
| 2mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued |
Product Information
Name:
(22R)-Budesonide
Controlled Product
Synonyms:
- (11b,16a)-16,17-[(1R)-Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
- (11β,16α)-16,17-[(1R)-Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
- 16a(R),17-(Butylidenebis(oxy))-11b,21-dihydroxypregna-1,4-diene-3,20-dione
- 2H-Naphth[2′,1′:4,5]indeno[1,2-d][1,3]dioxole, pregna-1,4-diene-3,20-dione deriv.
- Dexbudesonide
- Pregna-1,4-diene-3,20-dione, 16,17-[(1R)-butylidenebis(oxy)]-11,21-dihydroxy-, (11β,16α)-
- Pregna-1,4-diene-3,20-dione, 16,17-[butylidenebis(oxy)]-11,21-dihydroxy-, [11β,16α(R)]-
Description:
(22R)-Budesonide is a steroid that has been used for the treatment of asthma, chronic cough, and bowel disease. It is also used to treat rhinitis symptoms in patients with allergic rhinitis or chronic sinusitis. (22R)-Budesonide inhibits the inflammatory response by inhibiting the release of inflammatory mediators such as eosinophil cationic protein, which are released during an allergic reaction. The drug is also effective in treating bacterial rhinosinusitis, although it has not been tested against other types of respiratory infections.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
430.53 g/mol
Formula:
C25H34O6
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
